Cleary Gottlieb actively represents a wide range of pharmaceutical and biotechnology companies in important corporate transactional matters and in precedent-setting antitrust, regulatory, arbitration, and litigation issues.

We also provide counsel to the financial institutions that advise and assist these companies in their capital markets financings. With 14 integrated global offices, our lawyers work assiduously on behalf of our clients to bridge borders and navigate multijurisdictional regulatory requirements to enable the mergers, acquisitions, joint ventures, capital-raisings, and other corporate transactions that meet their business goals.